Bayer | BAYN - Beneficio Bruto En Ventas





Beneficio Bruto En Ventas Cambio Fecha
Air Liquide EUR 8.65B 4.44B 2024-12
Akzo Nobel EUR 978M 42M 2026-03
Alcon AG USD 1.68B 16M 2026-06
Amarin USD 23.17M 961K 2025-12
Arkema EUR 384.1M 70.9M 2026-03
AstraZeneca USD 12.86B 251M 2026-06
BASF EUR 4.33B 181M 2026-06
Bayer EUR 6.33B 1.84B 2026-06
Beiersdorf EUR 1.54B 1.16B 2025-06
Corteva USD 2.37B 876M 2026-03
Covestro EUR 212M 276M 2025-12
Essilor EUR 9.41B 1.12B 2026-06
Fresenius EUR 1.55B 16M 2026-06
Fresenius Medical Care EUR 1.31B 130.98M 2026-06
Genmab DKK 1.07B 240M 2026-06
Givaudan CHF 1.55B 140M 2025-12
GlaxoSmithKline GBP 6.51B 757M 2026-06
GRIFOLS EUR 704M 84M 2026-06
Hikma Pharmaceutical USD 362.5M 329.5M 2025-06
Johnson Matthey GBP 480M 33M 2024-06
Linde USD 4.26B 991M 2026-03
Lonza CHF 1.29B 248M 2025-06
Merck EUR 3.17B 101M 2026-06
Novartis USD 11.24B 1.18B 2026-06
Nutrien USD 3.25B 1.61B 2026-06
Philips EUR 2.15B 384M 2026-06
PPG Industries USD 1.81B 153M 2026-06
Roche Holding CHF 22.69B 600M 2026-06
Sanofi EUR 8.71B 602M 2026-06
SAP EUR 6.97B 149M 2026-03
Solvay EUR 213M 53M 2026-06
UCB EUR 3.19B 621M 2025-12
Umicore EUR 308.6M 10.45M 2024-12
Vinci EUR 2.44B 27.34B 2025-06